3,4-dihydroxyphenylacetic acid has been researched along with 2-methyltryptoline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, MA; Neafsey, EJ | 1 |
Cheng, BY; Christensen, MA; Collins, MA; Hurley-Gius, D; Hurley-Gius, K; Neafsey, EJ; Pronger, DA; Ung-Chhun, NA | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 2-methyltryptoline
Article | Year |
---|---|
Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Aotus trivirgatus; Carbolines; Caudate Nucleus; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Indoles; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Serotonin; Substantia Nigra | 1985 |
Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Aotus trivirgatus; Brain; Carbolines; Dopamine; Homovanillic Acid; Mice; Mice, Inbred C57BL; Parkinson Disease, Secondary; Pyridines; Structure-Activity Relationship | 1987 |